These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2524856)

  • 21. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI.
    Arnt J; Hyttel J
    Eur J Pharmacol; 1989 Feb; 161(1):45-51. PubMed ID: 2524390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanistic studies on DOM as a discriminative stimulus.
    Glennon RA; Hauck AE
    Pharmacol Biochem Behav; 1985 Dec; 23(6):937-41. PubMed ID: 2934750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin and other serotonergic agonists on performance in a radial maze: a possible role for 5-HT1A receptors in memory.
    Winter JC; Petti DT
    Pharmacol Biochem Behav; 1987 Aug; 27(4):625-8. PubMed ID: 2958885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys.
    Li JX; Koek W; Rice KC; France CP
    J Pharmacol Exp Ther; 2010 Apr; 333(1):244-52. PubMed ID: 20053932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism.
    Goodwin GM; De Souza RJ; Wood AJ; Green AR
    Psychopharmacology (Berl); 1986; 90(4):488-93. PubMed ID: 2949333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Release of endogenous aspartate from rat cerebellum slices and synaptosomes: inhibition mediated by a 5-HT2 receptor and by a 5-HT1 receptor of a possibly novel subtype.
    Maura G; Barzizza A; Folghera S; Raiteri M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):229-36. PubMed ID: 1830929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
    Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
    Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat.
    Dugovic C; Wauquier A; Janssen PA
    Neuropharmacology; 1989 Dec; 28(12):1431-3. PubMed ID: 2482460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective activation of 5HT1A receptors induces lower lip retraction in the rat.
    Berendsen HH; Jenck F; Broekkamp CL
    Pharmacol Biochem Behav; 1989 Aug; 33(4):821-7. PubMed ID: 2533357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulus properties of tiflucarbine: a novel antidepressant agent.
    Glennon RA; De Vry J; Spencer DG; Glaser T
    Pharmacol Biochem Behav; 1990 Dec; 37(4):769-71. PubMed ID: 2151199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats.
    Jackson HC; Kitchen I
    Neuropharmacology; 1989 Jun; 28(6):635-42. PubMed ID: 2526930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
    Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG
    Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA; Martin KF
    Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors.
    Geyer MA; Tapson GS
    Neuropsychopharmacology; 1988 May; 1(2):135-47. PubMed ID: 3150805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
    Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin receptors in the rat nucleus tractus solitarii and cardiovascular regulation.
    Shvaloff A; Laguzzi R
    Eur J Pharmacol; 1986 Dec; 132(2-3):283-8. PubMed ID: 3102261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characterization of release-regulating serotonin autoreceptors in rat cerebellum.
    Bonanno G; Maura G; Raiteri M
    Eur J Pharmacol; 1986 Jul; 126(3):317-21. PubMed ID: 2944750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.